PubRank

Jorge A Marrero

Author PubWeight™ 87.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 16.40
2 Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008 4.73
3 Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol 2013 3.41
4 Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 2012 3.04
5 Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012 2.57
6 Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011 2.48
7 Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol 2005 2.26
8 MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008 2.19
9 Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology 2011 1.98
10 Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007 1.96
11 Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 2011 1.94
12 Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology 2010 1.80
13 Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 2007 1.65
14 Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl 2007 1.61
15 Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res 2005 1.55
16 SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 2005 1.55
17 Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 2009 1.49
18 Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012 1.49
19 Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol 2011 1.46
20 Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 2012 1.44
21 Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci 2013 1.43
22 Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol 2013 1.39
23 Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol 2004 1.39
24 Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010 1.38
25 Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol 2007 1.33
26 An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009 1.31
27 Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol 2006 1.17
28 Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 2013 1.11
29 Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 2010 1.09
30 Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep 2008 1.05
31 Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol 2013 0.97
32 Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 2010 0.96
33 Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci 2010 0.94
34 Current approaches to the treatment of early hepatocellular carcinoma. Oncologist 2010 0.93
35 Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice. Clin Gastroenterol Hepatol 2004 0.92
36 Staging systems for hepatocellular carcinoma: should we all use the BCLC system? J Hepatol 2006 0.92
37 Viral hepatitis and hepatocellular carcinoma. Arch Med Res 2007 0.90
38 Screening process failures for hepatocellular carcinoma. J Natl Compr Canc Netw 2014 0.90
39 Hepatocellular carcinoma. Curr Opin Gastroenterol 2004 0.90
40 Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation 2006 0.86
41 Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit? Gastroenterology 2004 0.85
42 A multidisciplinary approach to the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 2010 0.84
43 Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw 2013 0.82
44 Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Rev Anticancer Ther 2009 0.80
45 Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Invest 2012 0.79
46 Can dietary fish intake prevent liver cancer? Gastroenterology 2012 0.78
47 Alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009 0.78
48 Interferon therapy and prevention of hepatocellular carcinoma in hepatitis C. Dig Dis Sci 2012 0.77
49 Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature. Liver Transpl 2006 0.77
50 Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients. Dig Dis Sci 2014 0.76
51 Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology 2008 0.76
52 Prevention of recurrent variceal bleeding: as easy as A.P.C.? Gastrointest Endosc 2002 0.75
53 Reply to Giannini and Trevisani. Am J Gastroenterol 2013 0.75
54 Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers. J Hepatol 2009 0.75
55 Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma. Transplantation 2017 0.75
56 Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Clin Adv Hematol Oncol 2013 0.75
57 Hepatocellular carcinoma. Curr Opin Gastroenterol 2002 0.75